Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Vincent Aurentz

SEC-identified person · CIK 1657494 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Inhibikase Therapeutics, Inc. IKT Director filed 2025–2026
Longboard Pharmaceuticals, Inc. LBPH Director filed 2021–2024
Arena Pharmaceuticals INC ARNA Executive VP and CBO filed 2016–2022
Zalicus Inc. ZLCS Chief Business Officer filed 2015–2016

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.